BioPharma Credit PLC

BPCR•London Stock Exchange

Financial Services United Kingdom Asset Management

Need professional-grade analysis? Visit stockanalysis.com

$0.94

+0.00%

End of day

Market Cap

$1.06B

P/E Ratio

8.69

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	4.24	0.00	1.55	1.05	1.33	1.37	1.33
Calmar	—	0.00	3.63	2.11	1.67	0.75	1.66
Sharpe	1.81	0.00	0.94	0.65	0.88	0.85	0.80
Omega	1.68	1.01	1.21	1.14	1.18	1.19	1.19
Martin	77.76	0.00	7.61	3.97	5.76	2.42	7.87
Ulcer	0.32	1.43	2.37	2.64	2.27	4.47	2.73

BioPharma Credit PLC (BPCR) Price Performance

BioPharma Credit PLC (BPCR) trades on London Stock Exchange in USD. The company is classified in the Financial Services sector under the Asset Management industry. The stock currently trades at $0.94.

Over the past year, BPCR has traded between a low of $0.77 and a high of $0.97. The stock has gained 13.6% over this period. It is currently 21.6% above its 52-week low.

BioPharma Credit PLC has a market capitalization of $1.06B, with a price-to-earnings ratio of 8.69.

About BioPharma Credit PLC

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. The company debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in Leeds, the United Kingdom.

Company Info

Sector: Financial Services
Industry: Asset Management
Exchange: London Stock Exchange
Currency: USD
Country: United Kingdom

Financial Metrics

Revenue (TTM): $124.46M
EBITDA: N/A
Profit Margin: 98.17%
EPS (TTM): N/A
Book Value: 1.02

Technical Indicators

52 Week High: $0.97
52 Week Low: $0.77
50 Day MA: $0.93
200 Day MA: $0.90
Beta: N/A

Valuation

Trailing P/E: 8.55
Forward P/E: N/A
Price/Sales: 8.53
Price/Book: 0.92
Enterprise Value: $1.06B